(Q39392824)

11 September 2017

title

Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population (English)

1 reference

11 September 2017

1 reference

4

Michael Kundi

1 reference

11 September 2017

6

Ursula Wiedermann

1 reference

11 September 2017

Pamela Rendi-Wagner

1

1 reference

11 September 2017

Maria Korinek

series ordinal

2

1 reference

11 September 2017

Birgit Winkler

series ordinal

3

1 reference

11 September 2017

Herwig Kollaritsch

series ordinal

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

18 September 2006

1 reference

11 September 2017

1 reference

11 September 2017

volume

25

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

927-931

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

11 September 2017

1 reference

Hepatitis A virus infections in travelers, 1988-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Risks of hepatitis A and B in the traveling public

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Inactivated hepatitis A vaccine: long-term antibody persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Persistence of vaccine-induced antibody to hepatitis A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Hepatitis A booster vaccination: is there a need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Six years' follow-up after hepatitis A vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Immunologic approaches to assessing the response to inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.044

10.1016/J.VACCINE.2006.08.044

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference